Advertisement
Letter to the Editor|Articles in Press

Response to “Do Higher Doses of Naloxone Increase the Risk of Pulmonary Complications?”

      We read with interest the article “Do Higher Doses of Naloxone Increase the Risk of Pulmonary Complications?” by Acus et al., as it attempted to answer an important clinical question (
      • Acus K
      • Krizo J
      • Prete S
      • et al.
      Do higher doses of naloxone increase the risk of pulmonary complications?.
      ). The article aimed to examine the effect of increasing doses of naloxone and its relationship to pulmonary complications in the setting of opioid toxicity. Because the opioid epidemic has been fueled by synthetic opioids (i.e., fentanyl and fentanyl analogs) and reports of “naloxone resistance” have occurred, understanding proper naloxone dosing and potential risks is critical (
      • Somerville NJ
      • O'Donnell J
      • Gladden RM
      • et al.
      Characteristics of fentanyl overdose - Massachusetts, 2014-2016.
      ).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Acus K
        • Krizo J
        • Prete S
        • et al.
        Do higher doses of naloxone increase the risk of pulmonary complications?.
        J Emerg Med. 2023; 64 (00–00)
        • Somerville NJ
        • O'Donnell J
        • Gladden RM
        • et al.
        Characteristics of fentanyl overdose - Massachusetts, 2014-2016.
        MMWR Morb Mortal Wkly Rep. 2017; 66: 382-386
        • Flamm ES
        • Young W
        • Collins WF
        • Piepmeier J
        • Clifton GL
        • Fischer B.
        A phase I trial of naloxone treatment in acute spinal cord injury.
        J Neurosurg. 1985; 63: 390-397
        • Bracken MB
        • Shepard MJ
        • Collins WF
        • et al.
        A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.
        N Engl J Med. 1990; 322: 1405-1411
        • Cohen MR
        • Cohen RM
        • Pickar D
        • Murphy DL
        • Bunney Jr., WE
        Physiological effects of high dose naloxone administration to normal adults.
        Life Sci. 1982; 30: 2025-2031
        • DiSalvo P
        • Su MK.
        Biostatistics and epidemiology for the toxicologist: incidence and prevalence.
        J Med Toxicol. 2022; 18: 56-57
        • Osler W.
        Oedema of the left lung-morphia poisoning.
        Montreal Gen Hosp Rep. 1880; 1: 291